Added to YB: 2025-11-13
Pitch date: 2025-11-11
NVTS [neutral]
Novartis India Limited
-3.52%
current return
Author Info
No bio for this author
Company Info
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands.
Market Cap
INR 20.0B
Pitch Price
INR 829.80
Price Target
N/A
Dividend
3.09%
EV/EBITDA
14.50
P/E
18.74
EV/Sales
3.90
Sector
Pharmaceuticals
Category
growth
NVTS Q3 2025 Financial Highlights
NVTS (earnings): Kitchen sink Q3 w/ $22M rev, Q4 guide $20.5M as mgmt kills legacy mobile charging biz. Betting on 'Navitas 2.0' - NVIDIA collab on 800V AI datacenter power, SiC modules for EVs/solar. OpEx cut 21% to $15M, $150M cash runway to 2026. High risk/reward at 20x P/S on FY25.
Read full article (8 min)